Bostwick Exits Bostwick Laboratories; Joins Start-Up Focused On Prostate Cancer
NORTH CHESTERFIELD, Va., Dec. 29, 2015 /PRNewswire/ -- After founding Bostwick Laboratories in 1999 and growing it into the number one medical laboratory for prostate cancer diagnosis in the United States, Dr. David G. Bostwick has departed and joined a start-up anatomic pathology group, Granger Diagnostics. He stated: "After selling Bostwick Laboratories more than four years ago, it is now time for me to return to my greatest passion in medicine: prostate cancer diagnosis and translational research." This veteran pathologist has published more than 500 peer-review medical journals and 15 books, including Urologic Surgical Pathology (3rd Edition, 2014), the best-selling book in the field, with emphasis on prostate cancer.
About Granger Diagnostics
Granger Diagnostics is a CLIA-certified anatomic, clinical, and molecular pathology reference laboratory specializing in the diagnosis and treatment of cancer and related conditions, with special focus on prostate cancer. Granger Diagnostics is the next step in the technologic evolution of the diagnostic medical laboratory, combining leading-edge technology-- including advanced bioinformatics-- with superb client services from highly-select Bostwick-trained veteran pathologists and laboratorians. Offerings include anatomic pathology, FISH, molecular testing, and next-generation sequencing through a nationwide network of laboratories and affiliates (North Chesterfield VA, Hapeville, GA, and (pending) Orlando, FL).
Granger has optimized the diagnosis of cancer and related diseases by employing the most advanced laboratory processes designed and built by experts with more than 30 years of experience in the field. This ensures rapid through-put and maximum accuracy in diagnosis. For every prostate biopsy, every minute counts, especially when it's your biopsy. And it better be accurateevery single time. That is why there is Granger Diagnostics.
Granger Diagnostics and affiliates provides research and development services and clinical testing to physicians and life science investigators in clinical practice, biotechnology and pharmaceutical companies, academic institutions, and several government agencies. Its services are offered individually or can be integrated to support product development from discovery to market with full regulatory support. Learn more about Granger Diagnostics at www.grangerdiagnostics.com.
CONTACT:
David G. Bostwick M.D., MBA
Granger Diagnostics, a division of AI Biotech
804-677-8527
Please visit http://www.grangerdiagnostics.com/ for more information.
Copyright © 2015 Granger Diagnostics. All Rights Reserved.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bostwick-exits-bostwick-laboratories-joins-start-up-focused-on-prostate-cancer-300197315.html
SOURCE Granger Diagnostics
